Procurement Summary
Country : Germany
Summary : Open House Contracts for Multiple Active Ingredients/Active Ingredient Combinations
Deadline : 03 Mar 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 80636470
Document Ref. No. : 167239-2023
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The subject of this publication is the conclusion of contracts according to Section 130a Paragraph 8 SGB V for the following active ingredients/active ingredient combinations as part of a so-called open-house procedure:
Dabigatran (B01AE07)
FormoterolWith the specification of uniform contract conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies are able to conclude a discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredients mentioned/Combinations of active ingredients offered.
The earliest start of the contract is May 1st, 2023. Based on this, the contract period is a maximum of 24 months.
Doc Title: Pharmaceutical products
Contract Type: Supplies
Document Type : Contract notice
Reference Number : 2023-03-16-NW-DRA-Open House
Contract Type : Supplies
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2023-03-16
Publish Date : 2023-03-21
Submission Date : 2025-03-03
Documents
Tender Notice